AUTHOR=Buchwald Peter 

TITLE=Quantification of signal amplification for receptors: the Kd/EC50 ratio of full agonists as a gain parameter

JOURNAL=Frontiers in Pharmacology

VOLUME=Volume 16 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1541872

DOI=10.3389/fphar.2025.1541872

ISSN=1663-9812

ABSTRACT=Concentration-response relationships connecting the concentration of ligands to the responses they produce are central to pharmacology in general and form the core of quantitative pharmacology. While typically they can be well-described by hyperbolic functions (sigmoid on commonly used semi-log scales) and characterized by half-maximal concentrations values (EC50), their connection to receptor occupancy, characterized in a similar manner by the equilibrium dissociation constant Kd, can be complex due to the intermixing of the effects from occupancy-induced activation with those from partial agonism, constitutive activity, and pathway-specific signal amplification. Here, it is proposed that, as long as both occupancy and response follow such typical concentration-dependencies, signal amplification can be quantified using the gain parameter gK = κ = Kd/EC50 measured for full agonists. This is similar to the gain parameter used in electronics (e.g., gV = Vout/Vin for voltage). On customarily used semi-log representations, log gK corresponds to the horizontal shift between the response and occupancy curves, logKd-logEC50, the presence of which (i.e., Kd > EC50) is generally considered as evidence for the existence of “receptor reserve” or “spare receptors”. The latter is a misnomer that should be avoided since even if there are excess receptors, there is no special pool of receptors “not required for ordinary use” as spare would imply. For partial agonists, the κ = Kd/EC50 shift is smaller than for full agonists as not all occupied receptors are active. The gK gain parameter (full agonist Kd/EC50) corresponds to the γ gain parameter of the SABRE receptor model, which includes parameters for Signal Amplification (γ), Binding affinity (Kd), and Receptor-activation Efficacy (ε); for partial agonists (ε < 1), SABRE predicts a corresponding shift of κ = εγ-ε+1.